Can spironolactone cause anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spironolactone and Anxiety

Spironolactone does not appear to cause anxiety as a common side effect based on available evidence, and it may even have positive effects on mood in some patients. 1

Side Effect Profile of Spironolactone

Spironolactone is a potassium-sparing diuretic that acts as an aldosterone antagonist and has anti-androgenic properties. According to clinical guidelines, the most commonly reported side effects include:

  • Menstrual irregularities (15-30%)
  • Diuresis (29%)
  • Breast tenderness or enlargement (3-5%)
  • Dizziness (3-4%)
  • Nausea (2-4%)
  • Polyuria (1-2%) 1

Notably, anxiety is not listed among the common side effects in current guidelines. The European Society of Cardiology guidelines for heart failure mention headache, diarrhea, fatigue, gynaecomastia, decreased libido, and menstrual disruption as the most common side effects (occurring in >10% of patients) 2.

Evidence Regarding Mood Effects

Some evidence suggests that spironolactone may actually have positive effects on mood in certain populations:

  • In a case series of women with fibromyalgia, spironolactone treatment was associated with improvements in anxiety and depression symptoms, as measured by the Fibromyalgia Impact Questionnaire. Positive mood increased from 20.0 ± 5.4 to 37.7 ± 5.4 (maximum score = 48), while negative mood decreased from 35.4 ± 5.3 to 10.0 ± 4.4 (maximum score = 60) 3.

  • A small study from 1978 suggested that spironolactone might be beneficial in manic-depressive disease, with 5 out of 6 patients being well-maintained on spironolactone after discontinuing lithium due to side effects 4.

Research on Spironolactone and Anxiety

One study specifically examined the effects of spironolactone on experimentally induced panic symptoms in healthy men. The researchers found that blockade of mineralocorticoid receptors with spironolactone had no effect on panic symptoms induced by cholecystokinin-tetrapeptide (CCK-4). While the drug did impair certain cognitive functions (selective attention, visuospatial memory, and mental flexibility), it did not increase anxiety 5.

Long-term Safety

Long-term safety studies of spironolactone are reassuring. An 8-year follow-up study of women taking spironolactone for acne found no serious illnesses attributed to the medication. While side effects were common (59% of patients), they were primarily related to diuretic effects and menstrual irregularities, not anxiety or mood disturbances 6.

Monitoring Recommendations

When prescribing spironolactone, monitoring should focus on:

  • Electrolytes and renal function: Check at 1 week, 1 month, and then every 3 months
  • Serum potassium levels: Levels exceeding 5.5 mEq/L are concerning
  • More frequent monitoring if dose is increased or if patient develops dehydration 1

Conclusion

While individual responses to medications can vary, the available evidence does not support anxiety as a common side effect of spironolactone. In fact, some evidence suggests potential mood benefits in certain populations. Clinicians should monitor for the well-documented side effects of spironolactone, particularly electrolyte disturbances, menstrual irregularities, and breast tenderness, but anxiety does not appear to be a significant concern with this medication.

References

Guideline

Hormone Therapy and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Spironolactone prophylaxis in manic-depressive disease.

The Journal of nervous and mental disease, 1978

Research

Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007

Research

Long-term safety of spironolactone in acne: results of an 8-year followup study.

Journal of cutaneous medicine and surgery, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.